Advertisement

Repair of Myotonic Dystrophy Protein Kinase (DMPK) Transcripts by Trans-Splicing Ribozymes

  • Leonidas A. Phylactou
Part of the Methods in Molecular Biology™ book series (MIMB, volume 252)

Abstract

The Tetrahymena group I intron ribozyme is an RNA molecule of approx 400 bases that is capable of base-specific RNA trans-splicing. These properties can be applied to repair mutations at the RNA level, and therefore can restore normal cellular functions in diseased cells. The purpose of this chaper is to present the methodology that can be used to repair mutations responsible for myotonic dystrophy. The design and construction of group I intron ribozymes and their transfection in myotonic dystrophy cells will be among the sections described in this chapter.

Keywords

Polymerase Chain Reaction Amplification Myotonic Dystrophy Dideoxy Sequencing High Fidelity Polymerase Chain Reaction Digested Plasmid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Cech, T. R., Zaug, A. J., and Grabowski, P. J. (1981) In vitro splicing of the ribosomal RNA precursor of Tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell 27, 487–496.PubMedCrossRefGoogle Scholar
  2. 2.
    Sullenger, B. A. and Cech, T. R. (1994) Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing. Nature 371, 619–622.PubMedCrossRefGoogle Scholar
  3. 3.
    Phylactou, L. A., Darrah, C., and Wood, M. J. A. (1998) Ribozyme-mediated trans-splicing of a trinucleotide repeat. Nat. Genet. 18, 378–381.PubMedCrossRefGoogle Scholar
  4. 4.
    Lan, N. Howery, R. P., Lee, S.-W., Smith, C. A., and Sullenger, B. A. (1998) Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors. Science 280, 1593–1596.PubMedCrossRefGoogle Scholar
  5. 5.
    Watanabe, T. and Sullenger, B. A. (2000) Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc. Natl. Acad. Sci. USA 97, 8490–8494.PubMedCrossRefGoogle Scholar
  6. 6.
    Jones, J. T., Lee, S.-W., and Sullenger, B. A. (1996) Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nat. Med. 2, 643–648.PubMedCrossRefGoogle Scholar
  7. 7.
    Kohler, U., Ayre, B. G., Goodman, H. M., and Haseloff, J. (1999) Trans-splicing ribozymes for targeted gene delivery. J. Mol. Biol. 285, 1935–1950.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2004

Authors and Affiliations

  • Leonidas A. Phylactou
    • 1
  1. 1.Laboratory of Molecular Function & TherapyThe Cyprus Institute of Neurology and GeneticsNicosiaCyprus

Personalised recommendations